Xstim spinal fusion stimulator approved in the US to promote bone healing

April 16, 2024 (Irving, Texas) Xstim, Inc., a pioneering developer and manufacturer of cutting-edge bone growth stimulation systems, is pleased to announce its recent premarket approval from the U.S. Food and Drug Administration (FDA) Application (PMA) for approval of Xstim™ spinal fusion stimulator.

Designed with patient comfort and convenience in mind, the Xstim™ Spinal Fusion Stimulator is an important milestone in the company’s line of bone growth stimulators. This capacitively coupled device emits a low-energy signal that is clinically proven to promote bone healing after spinal fusion surgery.

The Xstim device is expected to be commercially available in the second quarter of this year, with a targeted phased release plan in place to ensure widespread adoption.
The Xstim device has been carefully designed to prioritize patient ease of use and wearability, providing a non-invasive alternative for selected cases. The Xstim device simplifies patient treatment management with its intuitive interface and sleek design, as well as its large onboard color display.

Dr. Adam Bruggerman commented on the importance of Xstim, saying: “Bone healing after spinal fusion surgery is critical to the successful treatment of patients. The advent of non-invasive bone growth stimulation options like Xstim has provided my patients with valuable Advantages. Its sleek design ensures simple treatment administration without the hassle of downloading and managing additional apps.”

Xstim, Inc. CEO Jeremy Perkins expressed the company’s commitment to raising the standard for spinal fusion rehabilitation, saying, “Xstim, Inc. is committed to helping patients and surgeons improve the quality of spinal fusion rehabilitation care. Launch of Xstim Spinal Fusion Stimulator “

About Xstim, Inc.

Xstim, Inc. is an advanced medical technology company revolutionizing bone growth stimulation solutions. Centered on innovation, patient well-being and clinical effectiveness, its mission is to redefine the benchmark of care in spinal fusion rehabilitation and beyond.